Real land

Project 01 · Kongo-Green

Licensed medicinal cultivation

Built for export

Held as equity

Kongo Central · First light Skip the film ↓
Agricultural investment group

Footpath through green hills in Kongo Central
Project 01 · Kongo-GreenKongo Central

We put institutional and individual capital behind licensed operators building regulated, high-value crop infrastructure on leased African ground.

Register interest → Project 01 ↓
Project 01 · Kongo-Green Kongo Central, DRC
In brief The project, plainly

Agric-Dev is an agricultural investment group. We partner with licensed operators developing regulated African land into an asset both institutions and individual investors can hold a direct stake in.

15 haLeasehold under GACP development
€9,790,000Total raise · 23% equity in Galvin Holding B.V.
€100Indicative entry per unit · retail route
Kongo Central grassland at first light
Project 01 · Kongo-Green · Kongo Central 15 ha · leasehold · GACP development

Our first project is Kongo-Green: a pharmaceutical-grade cannabis cultivation, processing and export facility on leased ground in Kongo Central Province, Democratic Republic of Congo, developed by Galvin Pharma SARL and held under Galvin Holding B.V. Built to GACP standard, engineered for the EU-GMP pathway, and instrumented so every batch can be traced from seed to certificate.

We do not farm, and this raise does not buy land. It funds Agric-Dev's equity position in the company that holds the lease, the licence and the operation: a stake that is divisible, so it can be sized for a single institutional allocation or a retail unit alike.

Rows of medicinal plants under glass in a licensed facility
GACP glasshouse · Reference standard
Entity
Agricultural investment group
Project 01
Kongo-Green · 15 ha · leasehold
Location
Kongo Central Province, DRC
Operator
Galvin Pharma SARL (DRC)
Holding company
Galvin Holding B.V. (Netherlands)
Standard
GACP, on the EU-GMP pathway
The raise
€9,790,000 · 23% equity in Galvin Holding B.V.
Participation
Units of the raise · indicative entry €100
Status
Licensing pathway in process · development staged
Programme status Updated September 2026
To be confirmedLease secured To be confirmedSite survey and record In processLicensing pathway To be confirmedFacility engineering OpenInvestor registration
Register interest → The licence register ↓
What this becomes

A scalable, future proof model

Kongo-Green is Project 01. Everything built for it: the lease, the licensing pathway, the engineering standard, the record. All of it is designed to be repeated. Project 02, Ngandu Estate, does not begin at zero. It begins from a template that regulators, banks and buyers have already accepted, and opens after the Project 01 raise.

The ambition is not a farm, and not a fund. It is the standard by which productive African land is titled, built, financed and held.

The pipeline Two projects · One template · In order

Two projects
One at a time

Kongo-Green is open now. Ngandu Estate, the group's own landed scheme, opens after the Project 01 raise closes. Registered investors hear first, and nothing opens early to make a date.

Licensed glasshouse cultivation rows, reference standard
01Open · registering now

Kongo-GreenKongo Central · DRC · Galvin Pharma SARL

A pharmaceutical-grade cultivation, processing and export facility on 15 leased hectares, built to GACP and engineered for the EU-GMP pathway. The raise funds Agric-Dev's equity position in Galvin Holding B.V., the company that holds the lease, the licence and the operation.

Ground
15 ha · leasehold
Operator
Galvin Pharma SARL
The raise
€9,790,000 · 23% equity + 3% warrant
Entry
Units from about €100
Project 01 · Open Register interest →
Rolling green hills of the Ngandu estate, Kongo Central
02Opens after Project 01

Ngandu EstateKwilu-Ngongo · Kongo Central · DRC

The group's own landed scheme: 1,800 acres held under customary clan title and managed under contract by Ngandu Estate Management, with a fifty-hectare licensed campus planned on it. Terms are released when it opens, to the registered list first.

Ground
1,800 acres · clan title
Campus
50 ha licensed GACP campus, planned
Manager
Ngandu Estate Management
Route
8 km to Kwilu-Ngongo · province of the Port of Matadi
Project 02 · After the Project 01 raise The estate ↗

Both projects share the template: the licensing pathway, the engineering standard and the record. What Project 01 proves, Project 02 inherits.

The country, for scale Equal-area projection · Identical scale

One continent,
nearly three Europes

DR Congo alone is almost one quarter of the European continent. Ukraine, France, Spain, Germany and Finland would fit inside its borders together. At this scale a province is the size of a country: Kongo-Green sits in Kongo Central, on the Atlantic side of the DRC, more than a thousand kilometres from the country's eastern regions

Africa30.4M km²
Europe10.2M km²
The same Congo · moved without resizing
2.34M km²of national territory
One quarterthe size of the European continent
Two thirdsthe size of Western Europe

Drawn from Natural Earth 1:110m in Lambert azimuthal equal-area projection at one scale. Equal areas on the page are equal areas on Earth; shape varies slightly by projection. Europe means the continent, not the EU

Rows of medicinal plants under glass in a licensed facility
Licensed glasshouse cultivation · The reference standard
The thesis

High-value regulated crops are the most demanding asset in agriculture, and the most defensible. Every hectare *titled*, every operator *licensed*, every harvest *traceable* from seed to export. Licenced, Secure, Recorded

Agric-Dev · Founding doctrine
The moment Why now

The window is open It is not open indefinitely

Demand is ahead of certified supply

Europe's largest regulated market imports more than nine tenths of what it consumes. Domestic licensed production there is capped at a fraction of demand, and certified capacity takes years to build rather than quarters. A shortfall of that shape does not close quickly.

The corridor is already proven

Certified African production has been clearing into European pharmaceutical supply chains since 2021. This is no longer a theory about what the continent could export. It is a route that works, with the paperwork to prove it.

The economics are geographic

That gap is filled today from Canada, the Netherlands, Portugal and Denmark. None of them are low-cost producers. Equatorial sun, natural rainfall and a low operating base grow the same certified material for a fraction of the cost, and that advantage is written into the latitude rather than into a business plan.

The ground is being taken

International capital is already acquiring African production land. Licensed, uncontested positions at scale are finite, and the ones with water on them and a road out of them go first.

First to certify, first to export

Galvin Pharma SARL already holds a pharmaceutical processing licence: authorisation to produce Active Pharmaceutical Ingredients, which puts it outside the limitations standard cannabis producers face. The same licence is being issued for the Kongo-Green entity. Being first in the DRC with a GMP- and GDP-certified processing plant and warehouse gives a first-mover position on certified exports, ahead of any comparably certified competitor.

One seed
One system

Germination
The holding 0
Hectares held under formal lease · Kongo-Green Leased · Licensed operator · GACP development
0%Equity in Galvin Holding B.V. · target
0%Warrant position · target
€0Indicative entry per unit · retail route
The programme 05 disciplines
The sequence Phase 01
Rolling estate grassland
00

Foundation

Ground secured under lease. The licensing pathway opened with ACOREP and the Ministry of Health. Soil, water and security baselined.

Palm above planted slopes
01

Ground works

Greenhouses, water, power and secure perimeter, built once, as permanent works, to the standard the end market demands.

Botanical specimen macro
02

Processing

Drying, extraction and an on-site laboratory on the GACP → EU-GMP pathway. Quality is engineered in, not inspected in.

Mature medicinal flower ahead of first harvest
03

First harvest

Cultivation begins under licence. Under the operator's plan the plantation produces its own seed stock by month twelve, with surplus sold to third parties: an early revenue line ahead of first export.

Container vessel and port cranes, certified product outbound
04

Export

Certified product moves to licensed international buyers, shipment by shipment, under full authorisation.

Map of Africa with the Democratic Republic of Congo highlighted in gold
05

Platform

By year three the plantation produces its own neem oil, cutting pest-control costs and opening a further third-party line. Processing and warehousing, held separately from cultivation, is expected to become the group's largest earner. Then the model repeats: Project 02 onward.

Phase 00 Phase 05 →
Why this ground

Land is not interchangeable

Pharmaceutical buyers do not audit a company first. They audit the place it grows in, the water it draws, and the road its product leaves by.

01

Equatorial light

Five degrees south of the equator: near-constant daylight hours and no winter. Growing conditions that do not stop for a season.

02

Water to audit standard

Sourced and metered at extraction and at use. Pharmaceutical buyers audit the water before they audit the crop.

03

An established province

Kongo Central is the DRC's Atlantic-facing province, home to the country's principal sea ports and to a long history of commercial agriculture.

04

A route to market

Within reach of the DRC's established export infrastructure to international pharmaceutical buyers.

05

Lease and licence

Ground held under formal lease, with the cultivation and export licensing pathway managed by an established in-country operator.

The project · 01

One site One operator One standard

Entity
Agricultural investment group
Project
Kongo-Green · Project 01
Operator
Galvin Pharma SARL (DRC)
Holding company
Galvin Holding B.V. (Netherlands)
Province
Kongo Central, DRC
Land tenure
Leasehold · 15 ha
Status
Licensing pathway in process
Representative
Robby Rorijs · Galvin Pharma SARL / Galvin Holding B.V.
Rolling green hills dotted with young trees
Kongo Central grassland · Plate 04
Wild flowering plants, Kongo Central
Native flora · Plate 05
Valley path through tall grass
Valley approach · Plate 06
Trees against a blue sky on Kongo Central grassland
Highland treeline · Plate 07
The structure How ownership works

Boring by design

The structure as designed: capital raised through Agric-Dev flows into a 23% equity position in Galvin Holding B.V., the company that holds Kongo-Green's lease, licence and operations. Retail and institutional capital sit in the same instrument, sized differently. Six links, each contractual, each verifiable.

01

The operator

Galvin Pharma SARL holds the lease and the cultivation licence pathway, and runs the facility in-country. They carry the farming.

02

The holding company

Galvin Holding B.V., in the Netherlands, sits above the operator and holds the corporate and IP structure.

03

The equity

Agric-Dev's raise of €9,790,000 buys a 23% stake in Galvin Holding B.V., plus a 3% warrant position. Cultivation, processing and warehousing sit in separate entities within the group, so each can serve third-party clients as well as Kongo-Green itself: a services and toll-processing line alongside the cultivation business.

04

The unit

The raise is divided into units priced from roughly €100, so the same equity position can be entered at retail or institutional scale.

05

The offtake

No crop is planted against hope. Contracted demand from licensed buyers precedes production: that is the rule the model is built on.

06

The record

Every unit is registered and, where the retail route is used, verifiable and transferable in the same way the platform tracks a batch.

The paper Three documents create the holding
i

Subscription

Your order and your funds, against a stated number of units in the raise.

ii

Investment agreement

The terms of Agric-Dev's 23% equity and warrant position in Galvin Holding B.V.

iii

Unit agreement

Your proportional economic interest in that position, identified and recorded against you by number.

Held together, the three give a recorded interest in a specific position in a specific company · Templates are released in the data room · Subject to counsel's confirmation

Equity does not remove risk. It changes what you hold when things go wrong: a season can fail, and the licence, the facility and the corporate structure remain.

Governance
Jurisdiction

Operations licensed in the DRC. The holding company in the Netherlands. Capital held through a regulated issuer.

Security

Holders' interests recorded against a stated equity position, not against a forecast.

Verification

Independent laboratory testing, audited accounts and third-party valuation.

Eligibility

Verified investors only. Automated KYC and sanctions screening before allocation.

Behind it Lease and licensing · In-country partnership and community relations · Regulated cultivation and processing operators · Corporate and offering structure · International offtake and export logistics

Named principals released with the documentation · Nothing here is built to be clever, it is built to survive due diligence

The people Six responsibilities · First principal named

Structures do not farm

Six responsibilities carry this project: the ground, the licence, the crop, the certificate, the capital and the corridor. Each one sits with a single individual who answers for it. The first principal is named below. Remaining names, portraits and credentials are released with the documentation, once consent and verification are complete.

Operator and regulatory

Robby Rorijs

Representative of Galvin Pharma SARL and Galvin Holding B.V. Lobbied for the DRC's registration with the INCB as a cannabis-producing country and for the country's adoption of the I2ES import and export system, and now consults directly to CMPC and ACOREP, the two government bodies behind every licence in the register below.

R·01 Galvin Pharma SARL · Galvin Holding B.V.

Group principal, Agric-Dev

Name to confirm

The investment group's own principal: the raise, the counterparty relationship and the pipeline of projects behind Kongo-Green.

R·02 Placeholder

Head of agronomy

Name to confirm

GACP cultivation, genetics, soil and water. Sets the standard the licensed operator is held to.

R·03 Placeholder

Quality and compliance

Name to confirm

Laboratory, batch release and the EU-GMP pathway. Nothing leaves the facility without a certificate.

R·04 Placeholder

Capital and structure

Name to confirm

Corporate structure, the offering, reporting and audit. Answerable to the paper trail, not to a forecast.

R·05 Placeholder

Export and logistics

Name to confirm

Permits, custody and the corridor out of the DRC to licensed buyers. Shipment by shipment.

R·06 Placeholder
Advisers and counsel Engaged by discipline, not by retainer

Lease and land

Lease review, boundary survey and tenure opinion on the site.

To be appointed

Legal counsel

Corporate, licensing and offering counsel, in country and offshore.

To be appointed

Market and offtake

Pharmaceutical import, distribution and market access in regulated markets.

To be appointed

Audit and valuation

Independent audit, third party valuation and financial reporting.

To be appointed

Placeholders remain placeholders. Nobody is named publicly without their consent and a credential that can be checked.

Principals and advisers are named in the data room

Standing The licence pathway · Status by document

A licence is either held or it is not

Agric-Dev invests. It does not cultivate, and it does not hold cultivation licences in its own name. Regulated work is performed by the licensed operator, Galvin Pharma SARL, and the register below states, document by document, what is confirmed, what is in process and what is still to be confirmed against the project's own paperwork. Where an item sits with the operator it says so. Where confirmation is outstanding, the light stays off.

Held In Process To be confirmed Green held · Amber in process · Unlit to be confirmed
ACultivation and activity
01

Exploitation licence (cultivation)Issued under Ministerial Order No. 1250/CAB/MIN/SPHP/038/DCA/CPh/2022, Art. 97. Status for the Kongo-Green entity to be confirmed from the cooperation agreement

ACOREP To be confirmed
02

Agricultural activity licence

Ministry of Agriculture To be confirmed
03

Business registration and tax identification

DGRAD To be confirmed
BImport and export
04

Import authorisation, medical cannabis

ACOREP To be confirmed
05

Export authorisationRequired before a single kilogram leaves the country. No export revenue is assumed before it is in hand

ACOREP and Ministry of Health To be confirmed
06

INCB registration and I2ES reportingThe DRC is registered with the INCB as a cannabis-producing country and reports through the I2ES import and export system

INCB, international Country level, in force
CProcessing and certification
07

Pharmaceutical processing and API authorisationAuthorisation to produce Active Pharmaceutical Ingredients. Stated by the operator; exact status for the Kongo-Green entity to be confirmed

ACOREP Held by Galvin Pharma SARL · in process for the Kongo-Green entity
08

GACP certificationA standard the facility is built to meet, not a certificate held today

Certification body Target standard, on completion of works
09

EU-GMP certificationTreat every price built on it as conditional

EU competent authority Pathway target · phase two
10

Product specification, THC and CBD parameters

ACOREP and Ministry of Health To be confirmed
DInspections, environment and land
11

Site inspection report

ACOREP To be confirmed
12

Environmental impact assessmentUnder DRC Law 11/009, required over five hectares. Confirmed either way before construction begins

Ministry of Environment To be confirmed
13

Site lease, 15 hectaresA formal lease, not customary tenure. The document is verified before it is marked held

Lessor and Galvin Pharma SARL Stated by the operator · copy to be verified
14

Hydrogeological surveyCommissioned before construction

Independent surveyor To be confirmed

Statuses reflect what the holder of each document has stated, and are marked as such until an independent check is complete. Items still to be confirmed against the Cooperation and Investment Structuring Agreement are shown unlit rather than guessed. Nothing on this page is a licence held by Agric-Dev. Copies are released to verified investors on request, with the holder's consent, alongside the verification note that accompanies each one.

Request the licence file→
The record Reference photography · Kongo Central
Wide rolling grassland at first light
Plate 08
Emerald river between palms
Plate 09
Tilled ridge and furrow crop rows
Plate 10
Rolling hills dotted with young trees
Plate 11
Still dark-green river beneath palm fronds
Plate 12
Wild flowering plants in the grass
Plate 13
Footpath winding through a green valley
Plate 14
Palm above planted slopes
Plate 15
Native seed spikes, macro
Plate 16
Container vessel and port cranes, certified product outbound
Plate 17
Treeline against a blue sky
Plate 18
Botanical specimen macro
Plate 19
Photography · Ngandu Estate, Project 02 · Kongo Central, DRC · Reference imagery for Project 01
Questions Straight answers

What am I actually buying?

A unit representing a proportional economic interest in Agric-Dev's equity position in Galvin Holding B.V. Not a share of a harvest, and not a claim on a specific parcel of land.

Can I get my money out?

Units are transferable and Agric-Dev arranges the resale: your units are re-allocated to an incoming holder and the proceeds come to you. Timing depends on demand when you sell and the price is set by the allocation then open, so neither is guaranteed. The equity position behind the unit stays recorded against you while you wait.

What if a licence does not come?

Agric-Dev does not hold the cultivation licence directly; Galvin Pharma SARL does, as the in-country operator. The terms that apply to the equity position if a licence is refused or lapses are set out in the offering documents, and are not summarised here.

Why equity in the operator, and not the crop?

Because a season can be lost to weather or disease, but the licence, the facility and the corporate structure survive a bad season. Your exposure is to the business, not to a single harvest.

Who is allowed to participate?

Eligible investors in permitted jurisdictions only, after verification. This is not open to everyone, and it is not intended to be.

What happens to the money?

It funds Agric-Dev's equity subscription into Galvin Holding B.V., under the terms of the Cooperation and Investment Structuring Agreement.

Is any of this legal?

The Democratic Republic of Congo has permitted cultivation for medical and scientific purposes under licence since 2021. Agric-Dev invests. Galvin Pharma SARL, the licensed operator, cultivates. Participation happens only through formal offering documents.

When does it open?

Documentation is released in sequence to registered investors, and allocation windows are announced to that list first. Registering costs nothing and commits you to nothing.

One day this will be ordinary

Today it is a decision
Register interest → The licence register ↑
Access · Open registration
About Agric-Dev →

Register once · Documentation follows in sequence · No newsletter